TY  - GEN
AU  - Baldini,E
AU  - Tibaldi,C
AU  - Chella,A
AU  - Angeletti,C A
AU  - Silvano,G
AU  - Andrei,A
AU  - Algeri,R
AU  - Conte,P F
TI  - Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer
SN  - 0923-7534
PY  - 1997///0714
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Agents, Alkylating
KW  - Antineoplastic Agents, Phytogenic
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Cisplatin
KW  - Confidence Intervals
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Ifosfamide
KW  - Lung Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Survival Rate
KW  - Treatment Outcome
KW  - Vinblastine
KW  - analogs & derivatives
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1093/oxfordjournals.annonc.a010726
ER  -